Assessment of DNase Activity by Ratiometric Fluorescence Resonance Energy Transfer
July 25th, 2025
This study presents a simple, user-friendly ratiometric FRET assay for the detection and quantitative assessment of DNase activity, and demonstrates its application in the analysis of a weak nuclease.
We are addressing the need for sensitive detection of weak nuclease activity that requires prolonged observation in various stage conditions. We developed this ratiometric FRET assay to detect and measure DNase activity of different biomolecules with high sensitivity and for extended time periods.
This assay enables the systematic evaluation of how experimental parameters like pH, temperature, and buffer composition affect DNase activity in real time. To begin, dilute the protein sample to an appropriate concentration in each buffer solution ranging from pH 4.8 to pH 6.5. Prepare the ratiometric FRET probe solution by dissolving the FRET probe in nuclease-free water at a concentration close to one micromolar or one picomole per microliter. Now, prepare three wells in a 96-well plate for each pH condition to be tested by adding 70 microliters of nuclease-free water and 10 microliters of 10X buffer to each well. In three separate wells, prepare the positive controls by combining the specified reagents. For the negative controls, substitute the protein sample with nuclease-free water. Induce the DNase reaction by adding the probe solutions to the mixtures containing DNase protein at different pH values. Mix all samples thoroughly ensuring bubbles do not form. Then, incubate the DNase samples containing the ratiometric FRET probe at 37 degrees Celsius using either a water bath or a temperature-controlled incubator for various durations depending on the strength of the DNase activity. Terminate all incubation reactions by adding 100 microliters of 250 millimolar Tris hydrochloric acid buffer at pH 8 to each well. This step also equalizes the pH across all samples. Immediately after pH equalization, use a spectrofluorometer to record the emission spectra of both donor and acceptor fluorophores. Perform measurements directly in the 96-well plate by exciting the donor fluorophore at 488 nanometers and simultaneously detecting emissions at 525 nanometers for the donor and 580 nanometers for the FRET-derived acceptor signal. Use the recorded fluorescence intensities to assess DNase activity for each sample. Then, calculate the FRET ratio using the given formula. Verify the cleavage of the FRET probe by loading 15 microliters of each sample onto a 20% denaturing polyacrylamide gel. Run the gel for one hour at 100 volts. Finally, place the gel on the tray of the documentation system equipped with a high-resolution color camera and acquired gel images. Denaturing polyacrylamide gel analysis revealed that incubation of the FRET probe with leukocyte elastase inhibitor, or LEI, at pH 4.8 for 24 hours led to its cleavage producing distinct fluorescein amidite, or FAM, and tetramethylrhodamine, or TAM, labeled fragments of different lengths. The size and labeling of the cleavage products indicated specific cuts near the apexes of both hairpins in the probe consistent with the unique fragmentation pattern produced by LEI and distinct from that of DNase II. Emission spectra of LEI-treated FRET probes showed maximal signal change at pH 5.2 followed by pH 4.8 and then pH 5.5 indicating peak DNase activity in this acidic range with no significant activity in the control sample. Quantitative analysis of FRET ratios confirmed that LEI exhibited significantly higher activity at pH 5.2 than at pH 4.8, and both were markedly higher than at pH 5.5 with activity dropping sharply above pH 5.5.
View the full transcript and gain access to thousands of scientific videos
Overview
This study presents a user-friendly ratiometric FRET assay for detecting and quantitatively assessing DNase activity. It demonstrates the assay's application in analyzing weak nuclease activity under various conditions.
Key Study Components
Area of Science
- Biochemistry
- Enzymology
- Fluorescence spectroscopy
Background
- Weak nuclease activity detection is challenging and requires sensitive methods.
- Prolonged observation is often necessary to assess DNase activity accurately.
- Ratiometric FRET assays provide a promising approach for real-time analysis.
- Experimental parameters such as pH and temperature can significantly affect enzyme activity.
Purpose of Study
- To develop a sensitive assay for DNase activity detection.
- To evaluate the effects of various conditions on DNase activity.
- To provide a systematic method for analyzing weak nuclease activity.
Methods Used
- Preparation of protein samples in different buffer solutions.
- Use of a ratiometric FRET probe for real-time monitoring.
- Incubation of samples at controlled temperatures.
- Analysis of fluorescence emissions to calculate DNase activity.
Main Results
- Distinct cleavage patterns were observed for the FRET probe with leukocyte elastase inhibitor.
- Peak DNase activity was noted at pH 5.2, with significant differences across pH levels.
- Quantitative analysis confirmed higher activity at lower pH values.
- Denaturing polyacrylamide gel analysis validated the cleavage results.
Conclusions
- The developed FRET assay is effective for sensitive detection of DNase activity.
- Experimental conditions significantly influence enzyme activity.
- This method can be applied to study various nucleases in different environments.
Frequently Asked Questions
Executive Industry Relevance
Quantitative assessment of DNase activity using ratiometric FRET enables sensitive detection of weak nucleolytic events under diverse biochemical conditions. This capability is critical for early-stage target validation and mechanistic de-risking in biopharma discovery pipelines, especially when evaluating enzyme modulators or characterizing off-target nuclease effects. The approach supports predictive confidence in lead selection and informs risk-adjusted portfolio decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables systematic interrogation of DNase activity across varying pH, temperature, and buffer conditions.
- Supports mechanistic de-risking by distinguishing specific cleavage patterns and enzyme behaviors.
- Facilitates functional validation of candidate targets or inhibitors with weak or slow activity profiles.
- Provides quantitative outputs for hypothesis-driven triage of enzyme modulators.
Screening & Assay Development
- Delivers reproducible, real-time readouts suitable for assay standardization and optimization.
- Supports preparation of validated biological systems for downstream screening workflows.
- Enables detection of minor or slow DNase activity, expanding assay utility to challenging targets.
- Provides quantitative FRET ratios for reliable compound evaluation and comparison.
Translational & Preclinical Research
- Aligns with disease-relevant system studies where nucleolytic activity may serve as a translational biomarker.
- Supports continuity from discovery through preclinical validation by enabling robust enzyme activity profiling.
- Facilitates risk-adjusted advancement decisions based on quantitative mechanistic data.
Pipeline & Workflow Integration
This ratiometric FRET assay integrates into the discovery continuum from early hypothesis testing through lead identification and preclinical enzyme characterization.
- Discovery Biology: Provides sensitive, quantitative assessment of DNase activity for pathway clarification and biological de-risking.
- Screening: Offers standardized, reproducible assay outputs for compound and condition evaluation.
- Analytics: Generates quantitative FRET ratios and gel-based validation for comparative analysis across experimental variables.
- Translational Research: Supports biomarker alignment and mechanistic continuity when nucleolytic activity is disease-relevant.
- Enterprise Reuse: Functions as a reusable platform for diverse nuclease and enzyme activity studies across programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in enzyme target validation.
- Operational Value: Enhances assay standardization, reproducibility, and scalability for high-throughput or extended studies.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by providing robust quantitative data.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of enzyme-targeted assets.
Implementation Considerations
- Requires expertise in fluorescence spectroscopy and quantitative assay design.
- Needs access to spectrofluorometers and gel documentation systems for data acquisition and validation.
- Demands rigorous cross-team standardization of probe preparation and measurement protocols.
- May require adaptation for different nucleases or model systems based on probe compatibility.
- Extended observation periods may be necessary for weak or slow-acting enzymes.
